Septerna, Common Stock Stock Current Valuation
| SEPN Stock | 24.28 0.88 3.76% |
Valuation analysis of Septerna, Common Stock helps investors to measure Septerna, Common's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. As of the 23rd of December 2024, Begin Period Cash Flow is likely to grow to about 31.6 M, while Cash is likely to drop about 65.5 M.
Overvalued
Today
Please note that Septerna, Common's price fluctuation is not too volatile at this time. Calculation of the real value of Septerna, Common Stock is based on 3 months time horizon. Increasing Septerna, Common's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Septerna, Common is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Septerna, Stock. However, Septerna, Common's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 24.28 | Real 23.01 | Hype 23.68 | Naive 22.6 |
The intrinsic value of Septerna, Common's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Septerna, Common's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Septerna, Common Stock helps investors to forecast how Septerna, stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Septerna, Common more accurately as focusing exclusively on Septerna, Common's fundamentals will not take into account other important factors: Septerna, Common Stock Company Current Valuation Analysis
Septerna, Common's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Septerna, Current Valuation Driver Correlations
Understanding the fundamental principles of building solid financial models for Septerna, Common is extremely important. It helps to project a fair market value of Septerna, Stock properly, considering its historical fundamentals such as Current Valuation. Since Septerna, Common's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Septerna, Common's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Septerna, Common's interrelated accounts and indicators.
Click cells to compare fundamentals
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Septerna, Common Stock has a Current Valuation of 0.0. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Biotechnology industry. The current valuation for all United States stocks is 100.0% higher than that of the company.
Septerna, Common Stock is currently under evaluation in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Biotechnology industry is at this time estimated at about 10.38 Billion. Septerna, Common adds roughly 0.0 in current valuation claiming only tiny portion of stocks in Biotechnology industry.Septerna, Fundamentals
| Total Debt | 169.24 M | ||||
| Number Of Employees | 68 | ||||
| Total Asset | 130.87 M | ||||
| Retained Earnings | (46.58 M) | ||||
| Working Capital | 105.76 M | ||||
| Net Asset | 130.87 M |
About Septerna, Common Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Septerna, Common Stock's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Septerna, Common using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Septerna, Common Stock based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Septerna, Common
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Septerna, Common position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Septerna, Common will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Septerna, Common could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Septerna, Common when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Septerna, Common - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Septerna, Common Stock to buy it.
The correlation of Septerna, Common is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Septerna, Common moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Septerna, Common Stock moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Septerna, Common can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Septerna, Common Piotroski F Score and Septerna, Common Altman Z Score analysis. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Septerna, Common. If investors know Septerna, will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Septerna, Common listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Septerna, Common Stock is measured differently than its book value, which is the value of Septerna, that is recorded on the company's balance sheet. Investors also form their own opinion of Septerna, Common's value that differs from its market value or its book value, called intrinsic value, which is Septerna, Common's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Septerna, Common's market value can be influenced by many factors that don't directly affect Septerna, Common's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Septerna, Common's value and its price as these two are different measures arrived at by different means. Investors typically determine if Septerna, Common is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Septerna, Common's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.